Are AMPA Receptor Positive Allosteric Modulators Potential Pharmacotherapeutics for Addiction?
Positive allosteric modulators (PAMs) of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors are a diverse class of compounds that increase fast excitatory transmission in the brain. AMPA PAMs have been shown to facilitate long-term potentiation, strengthen communication between v...
Main Authors: | Lucas R. Watterson, M. Foster Olive |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/7/1/29 |
Similar Items
-
Positive allosteric modulation of AMPA receptors via PF4778574 leads to reduced demyelination and clinical disability in experimental models of multiple sclerosis
by: Mustafa Sindi, et al.
Published: (2025-03-01) -
Prospects for the use of allosteric drugs in real-world clinical practice
by: I. R. Svechkareva, et al.
Published: (2023-12-01) -
Design, Synthesis, and Biological Assessment of Novel Vanillin-Isoxazole Derivatives as Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptor
by: Santiago Stabile, et al.
Published: (2023-11-01) -
Positive Allosteric Modulators of Type 5 Metabotropic Glutamate Receptors (mGluR5) and Their Therapeutic Potential for the Treatment of CNS Disorders
by: Richard M. Cleva, et al.
Published: (2011-03-01) -
Positive allosteric modulation of mGluR5 accelerates extinction learning but not relearning following methamphetamine self-administration
by: Peter R Kufahl, et al.
Published: (2012-11-01)